BP1097
Lamotrigine
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 84057-84-1
Synonym(S): 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, GI 267119X
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | BP1097-200-MG | In Stock | ₹ 20,794.83 |
BP1097 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 20,794.83
GST (18%): ₹ 3,743.069
Total Price: ₹ 24,537.899
grade
pharmaceutical primary standard
API family
lamotrigine
form
solid
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI
1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Lamotrigine United States Pharmacopeia (USP) Reference Standard | 84057-84-1 | MFCD00865333 | 150MG | -- | ₹ 1,45,977.80 | ||
Sigma Aldrich Fine Chemicals Biosciences Lamotrigine >=98%, powder | 84057-84-1 | MFCD00865333 | 50MG | -- | ₹ 73,934.08 | ||
Sigma Aldrich Fine Chemicals Biosciences Lamotrigine European Pharmacopoeia (EP) Reference Standard | 84057-84-1 | MFCD00865333 | | -- | ₹ 24,531.07 | ||
Sigma Aldrich Fine Chemicals Biosciences Lamotrigine for system suitability European Pharmacopoeia (EP) Reference Standard | 84057-84-1 | MFCD00865333 | | -- | ₹ 16,681.27 | ||
Sigma Aldrich Fine Chemicals Biosciences Lamotrigine >=98%, powder | 84057-84-1 | MFCD00865333 | 10MG | -- | ₹ 18,643.72 | ||
Lamotrigine | -- | ₹ 12,459.58 | ||
Lamotrigine | -- | ₹ 1,29,066.48 | ||
Lamotrigine for system suitability | -- | ₹ 14,072.50 | ||
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine | -- | ₹ 445.00 - ₹ 64,347.00 | ||
Lamotrigine | -- | ₹ 1,335.00 - ₹ 16,020.00 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Lamotrigine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Lamotrigine TabletsLamotrigine Dispersible Tablets
- Biochem/physiol Actions: Anticonvulsant.
- Packaging: Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable